Abstract:Most conventional chemotherapeutics indiscriminately kill both cancerous and healthy cells and cause toxic side effects, limiting the maximum tolerated dose and thereby compromising therapeutic efficacy. To address this challenge, here dual-targeting intelligent DNA guided missile (GM)-integrated nanospacecraft (NSC) (abbreviated as GM-NSC) is demonstrated for staged chemotherapeutic drug delivery exclusively into cancer cells and then mitochondria (not into healthy cells). GM-NSC is essentially a core/shell nanocomposite composed of gold nanoparticles (AuNPs) surrounded by a high-density multilayer DNA crown that is self-assembled from DNA tetrahedral units (DNA Tetra) in a highly ordered manner. Each tetrahedral structural unit is equipped with three functional components: a cancer cell-targeting aptamer pointing toward the outside environment, a hidden mitochondria-targeting triphenylphosphonium (TPP), and an explosive bolt (E-bolt). GM-NSC can remain intact in fetal bovine serum solution over 12 h and has 53-fold improved systemic stability. Each GM-NSC accommodates 1250 anticancer doxorubicin (Dox), achieving a 48-63-fold improved drug payload capacity. When systemically administrated into a tumor-bearing xenograft murine model, Dox-loaded GM-NSC enters into tumor sites with 18-fold improved specificity followed by autonomous separation of GMs from the NSC core and specific mitochondrial accumulation due to the explosion of E-bolt upon stimuli of endogenous miRNAs. About 80% of Dox uptaken is transferred into mitochondria and induces mitochondria-mediated apoptosis. As a result, the growth of malignant tumor is almost 100% inhibited without detectable toxicity to healthy tissues. Due to the desirable systemic stability, good biocompatibility, high cargo loading capability, satisfactory in vivo biodistribution, and therapeutic efficacy without adverse effects, intelligible GM-NSC is expected to become an alternative drug delivery system for precision cancer therapy.

Endogenous Mrna Triggered DNA‐Au Nanomachine for in Situ Imaging and Targeted Multimodal Synergistic Cancer Therapy

Biomimetic Metallacage Nanoparticles with Aggregation-Induced Emission for NIR-II Fluorescence Imaging-Guided Synergistic Immuno-Phototherapy of Tumors

Deformable Smart DNA Nanomachine for Synergistic Intracellular Cancer-Related miRNAs Imaging and Chemo-Gene Therapy of Drug-Resistant Tumors

Dual-microRNA Triggered and DNA-programmed Nanomachine for Subtype-Based Detection and Tailored Treatment of Breast Cancer Cells

Telomerase-activated Au@DNA Nanomachine for Targeted Chemo-Photodynamic Synergistic Therapy

Aptamer-Modified Nb2C Multifunctional Nanomedicine for Targeted Photothermal/Chemotherapy Combined Therapy of Tumor

In vivo Imaging-Guided Nanoplatform for Tumor Targeting Delivery and Combined Chemo-, Gene- and Photothermal Therapy.

A "dual-key-and-lock" DNA nanodevice enables spatially controlled multimodal imaging and combined cancer therapy

Endogenous Dual Mirna-Triggered Dynamic Assembly of DNA Nanostructures for In-Situ Dual Sirna Delivery

A Tumour Mrna-Triggered Nanoassembly for Enhanced Fluorescence Imaging-Guided Photodynamic Therapy.

Tumor Microenvironment-Triggered Fabrication of Gold Nanomachines for Tumor-Specific Photoacoustic Imaging and Photothermal Therapy

In Situ Amplification of Intracellular Microrna with Mnazyme Nanodevices for Multiplexed Imaging, Logic Operation, and Controlled Drug Release

Nir-Activated Spatiotemporally Controllable Nanoagent For Achieving Synergistic Gene-Chemo-Photothermal Therapy In Tumor Ablation

Upconversion Nanoparticle@Au Core-Satellite Assemblies for in Situ Amplified Imaging of MicroRNA in Living Cells and Combined Cancer Phototherapy

Target-Induced Core-Satellite Nanostructure Assembly Strategy for Dual-Signal-On Fluorescence Imaging and Raman Quantification of Intracellular MicroRNA Guided Photothermal Therapy

Endogenous Mirna-Activated DNA Nanomachine for Intracellular Mirna Imaging and Gene Silencing

Multi-responsive nanotheranostics with enhanced tumor penetration and oxygen self-producing capacities for multimodal synergistic cancer therapy

Intelligent Gold Nanoparticles with Oncogenic MicroRNA‐Dependent Activities to Manipulate Tumorigenic Environments for Synergistic Tumor Therapy

Endogenous Stimuli-Responsive Autonomous Separation of Dual-Targeting DNA Guided Missile from Nanospacecraft for Intelligent Targeted Cancer Therapy

Nanoplex Delivery of Sirna and Prodrug Enzyme for Multimodality Image-Guided Molecular Pathway Targeted Cancer Therapy.

Theranostic Nanoplatform Based on Polydopamine-Coated Magnetic Mesoporous Silicon for Precise Cancer Triplex Nanotherapy and Multimodal Imaging